Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
209M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
61.5M
-
Shares change
-
+1.27M
-
Total reported value, excl. options
-
$193M
-
Value change
-
+$3.49M
-
Put/Call ratio
-
0.62
-
Number of buys
-
32
-
Number of sells
-
-30
-
Price
-
$3.13
Significant Holders of Invivyd, Inc. - Common Stock (IVVD) as of Q3 2022
84 filings reported holding IVVD - Invivyd, Inc. - Common Stock as of Q3 2022.
Invivyd, Inc. - Common Stock (IVVD) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.5M shares
of 209M outstanding shares and own 29.41% of the company stock.
Largest 10 shareholders include FMR LLC (15.1M shares), M28 Capital Management LP (9.25M shares), Alphabet Inc. (5.68M shares), ORBIMED ADVISORS LLC (5.27M shares), VANGUARD GROUP INC (3.82M shares), Slate Path Capital LP (3.74M shares), BlackRock Inc. (3.48M shares), 683 Capital Management, LLC (3.39M shares), Bain Capital Life Sciences Investors, LLC (1.94M shares), and Redmile Group, LLC (1.92M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.